Cite
Fohner AE, Dalton R, Skagen K, et al. Characterization of CYP3A pharmacogenetic variation in American Indian and Alaska Native communities, targeting CYP3A4*1G allele function. Clin Transl Sci. 2021;14(4):1292-1302doi: 10.1111/cts.12970.
Fohner, A. E., Dalton, R., Skagen, K., Jackson, K., Claw, K. G., Hopkins, S. E., Robinson, R., Khan, B. A., Prasad, B., Schuetz, E. G., Nickerson, D. A., Thornton, T. A., Dillard, D. A., Boyer, B. B., Thummel, K. E., & Woodahl, E. L. (2021). Characterization of CYP3A pharmacogenetic variation in American Indian and Alaska Native communities, targeting CYP3A4*1G allele function. Clinical and translational science, 14(4), 1292-1302. https://doi.org/10.1111/cts.12970
Fohner, Alison E, et al. "Characterization of CYP3A pharmacogenetic variation in American Indian and Alaska Native communities, targeting CYP3A4*1G allele function." Clinical and translational science vol. 14,4 (2021): 1292-1302. doi: https://doi.org/10.1111/cts.12970
Fohner AE, Dalton R, Skagen K, Jackson K, Claw KG, Hopkins SE, Robinson R, Khan BA, Prasad B, Schuetz EG, Nickerson DA, Thornton TA, Dillard DA, Boyer BB, Thummel KE, Woodahl EL. Characterization of CYP3A pharmacogenetic variation in American Indian and Alaska Native communities, targeting CYP3A4*1G allele function. Clin Transl Sci. 2021 Jul;14(4):1292-1302. doi: 10.1111/cts.12970. Epub 2021 Jan 27. PMID: 33503331; PMCID: PMC8301563.
Copy
Download .nbib